Tacrolimus injection should only be given under the supervision of a doctor who is experienced in treating people who have had an organ transplant and in prescribing medications that decrease the activity of the immune system.

The global Tacrolimus Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Tacrolimus Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tacrolimus Injection market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Tacrolimus Injection in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Tacrolimus Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Astellas Pharma
Pfizer
Jina Pharma
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
5 mg/mL
Type II

Segment by Application
Adult
Children